Document Detail

Growth of G422 glioma implanted in the mouse brain was affected by the immune ability of the host.
MedLine Citation:
PMID:  22088459     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: It is generally accepted that gliomas are the most common primary brain tumors with poor prognosis. We aimed to explore the relationship of the immunity of the central nervous system and the genesis and development of glioma.
METHODS: G422 glioma was implanted in the brain of BALB/c mice (immuno-competent mice), nude mice (T cell related immuno-deficient) and complement C3 knock-out mice (complement C3 related immunodeficient). The survival time of the host, growth and histopathology of the tumor, and concentrations of tumor necrosis factor-α (TNF-α) and interferon-γ (INF-γ) in tumor tissues were assessed.
RESULTS: Tumor spheres were formed in all mice after injection, and glial fibrillary acidic protein (GFAP) positive staining of the cells declared their glioma origin. The longest median survival time of (44.3 ± 6.0) days was found in BALB/c mice, followed by (24.8 ± 5.2) days in nude mice and the shortest (18.6 ± 5.8) days in complement C3 knock-out mice. Accordingly, the growth of the tumor was fastest in complement C3 knock-out mice, followed by the nude mice and slowest in the BALB/c mice. Although the proportions of infiltrating CD68(+) lymphocytes in tumor tissues showed no significant difference (P > 0.05), TNF-α level in the nude and C3 knock-out mice, (28.11 ± 4.86) µmol/L and (22.87 ± 6.36) µmol/L respectively, were significantly lower (P < 0.01) than that in the BALB/c mice, which was (230.21 ± 39.17) µmol/L. The INF-γ level was highest in the BALB/c mice ((180.76 ± 29.19) µmol/L), followed by the nude mice ((113.46 ± 23.76) µmol/L) and then the C3 knock-out mice ((16.84 ± 4.45) µmol/L).
CONCLUSIONS: The G422 glioma implanted in the brains of mice with different immune ability would be a useful model for studying the relationship of the immune system and tumor in the central nervous system. Furthermore, the T cells and complement C3 compartments of the immune response may affect the growth of implanted tumors and inflammatory factors such as TNF-α and INF-γ.
Ying-Xin Cheng; Fei Li; Jia-You Lu; Mei Li; Peng DU; Gui-Lian Xu; Hua Feng
Related Documents :
11783939 - The influence of uv exposure on 5-aminolevulinic acid-induced protoporphyrin ix product...
8983179 - A transgenic mouse model that recapitulates the clinical features of both neonatal and ...
22505209 - Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cel...
9645799 - Mouse parvovirus infection potentiates allogeneic skin graft rejection and induces syng...
16982879 - Induction of c3 and ccl2 by c3a in keratinocytes: a novel autocrine amplification loop ...
9082779 - Animal model of focal tonsillar infection: human tonsillar lymphocytes induce skin lesi...
8565289 - Both in vitro and in vivo irradiation are associated with induction of macrophage-deriv...
15143479 - Impairment of growth of listeria monocytogenes in thp-1 macrophages by granulocyte macr...
9147389 - The promoter of macrophage colony-stimulating factor receptor is active in astrocytes.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  124     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-11-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  1994-8     Citation Subset:  IM    
Department of Neurosurgery, Southwest Hospital, the Third Military Medical University, Chongqing 400038, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression of Smad7 inhibits fibrogenic responses of keratocytes to transforming growth factor ?2.
Next Document:  Sutureless choledochoduodenostomy with an intraluminal degradable stent in dog model.